Caseware UK (AP4) 2016.0.181 2016.0.181 2017-03-312017-03-31truetrueThe principal activity is that of a dormant companytrue2016-04-01 08699783 2016-03-31 08699783 2016-04-01 2017-03-31 08699783 2017-03-31 08699783 c:Director1 2016-04-01 2017-03-31 08699783 d:CurrentFinancialInstruments 2017-03-31 08699783 d:CurrentFinancialInstruments 2016-03-31 08699783 d:Non-currentFinancialInstruments 2017-03-31 08699783 d:Non-currentFinancialInstruments 2016-03-31 08699783 c:OrdinaryShareClass1 2016-04-01 2017-03-31 08699783 c:OrdinaryShareClass1 2017-03-31 08699783 c:EntityHasNeverTraded 2016-04-01 2017-03-31 08699783 c:FRS102 2016-04-01 2017-03-31 08699783 c:AuditExempt-NoAccountantsReport 2016-04-01 2017-03-31 08699783 c:FullAccounts 2016-04-01 2017-03-31 08699783 c:PrivateLimitedCompanyLtd 2016-04-01 2017-03-31 08699783 d:Subsidiary1 2017-03-31 08699783 d:Subsidiary1 2016-04-01 2017-03-31 08699783 d:Subsidiary1 1 2016-04-01 2017-03-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 08699783









BAGLEY BIOGAS LIMITED







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2017

 
BAGLEY BIOGAS LIMITED
REGISTERED NUMBER: 08699783

BALANCE SHEET
AS AT 31 MARCH 2017

2017
2016
Note
£
£

  

Fixed assets
  
50
100

Current assets
  
1
1

Creditors: amounts falling due within one year
 5 
(50)
(100)

Net current liabilities
  
 
 
(49)
 
 
(99)

Total assets less current liabilities
  
1
1

  

Net assets
  
1
1


  

Capital and reserves
  
1
1


For the year ended 31 March 2017 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 



Robert George Kennerley
Director

Date: 10 July 2017
The notes on pages 2 to 4 form part of these financial statements.

img2bce.pngPage 1

 
BAGLEY BIOGAS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2017

1.


General information

Bagley Biogas Limited, is a private limited company, limited by shares, incorporated in England and Wales, with its registered office address and principal place of business at Belmont House, Shrewsbury Business Park, Shrewsbury, SY2 6LG. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

 
2.2

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the Profit and loss account for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

Investments in listed company shares are remeasured to market value at each Balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.

 
2.3

Financial instruments

The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in case of an out-right short-term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Profit and loss account.

 
2.4

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

img4608.pngPage 2

 
BAGLEY BIOGAS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2017

3.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 April 2016
100


Disposals
(50)



At 31 March 2017

50






Net book value



At 31 March 2017
50



At 31 March 2016
100

Subsidiary undertakings

The following were subsidiary undertakings of the Company:

Name
Country of
incorporation
Class of shares
Holding
Principal activity

Bagley Biogas (Trading) Unlimited
England
Ordinary
 100%
Production of gas from waste material


The aggregate of the share capital and reserves as at 31 March 2017 and of the profit or loss for the year ended on that date for the subsidiary undertakings were as follows:

Aggregate of share capital and reserves
Profit/(loss)
£
£
Bagley Biogas (Trading) Unlimited

(392,958)

(121,173)

(392,958)

(121,173)

img7c37.pngPage 3

 
BAGLEY BIOGAS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2017

4.


Debtors


2017
2016
£
£


Amounts owed by group undertakings
1
1

1
1



5.


Creditors: Amounts falling due within one year

2017
2016
£
£

Amounts owed to group undertakings
50
100

50
100



6.


Share capital

2017
2016
£
£
Shares classified as equity

Allotted, called up and fully paid



1 Ordinary share of £1
1
1


7.


Related party transactions

At the year end the company owed £50 (2016: £100) to Bagley Biogas (Trading) Unlimited, a subsidary company.
At the year end the company wsa owed £1 (2016: £1) by Bagley Biogas (Holdings) Limited, its parent company.


8.


Controlling party

The controlling party of the entity is Bagley Biogas (Holdings) Limited which owns 100% of the issued share capital.


9.


First time adoption of FRS 102

The policies applied under the entity's previous accounting framework are not materially different to FRS 102 and have not impacted on equity or profit or loss.

img06c7.pngPage 4